Nephros (NEPH) EBITDA (2009 - 2026)
Nephros' EBITDA came in at $1.85 million for Q2 2026, up 559.4% from $281,000 a year earlier.
Powered by 
Analysis
Nephros (NEPH) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Nephros reported EBITDA of $2.38 million, up 60.7% year-over-year; for FY2025, it was $1.29 million, up 798.6% from FY2024.
- Going back by year, EBITDA was $143,000 in FY2024, -$1.38 million in FY2023, -$3.98 million in FY2022 and -$2.79 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBITDA in data going back to Q2 2010.
- Year-over-year, EBITDA increased in two of the last four quarters, with growth averaging 109.9%.
- Business Quant data shows NEPH's EBITDA at $124,000 (Q1 2026), $50,000 (Q4 2025) and $348,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.20 Bn | 235.84 Bn | 5.13 Bn | 3.09 Bn |
| 2 | Abbott Laboratories | 185.80 Bn | 160.26 Bn | 7.39 Bn | 2.61 Bn |
| 3 | Danaher | 163.29 Bn | 142.96 Bn | 3.84 Bn | 1.97 Bn |
| 4 | Intuitive Surgical | 152.47 Bn | 132.89 Bn | 2.08 Bn | 789.70 Mn |
| 5 | Medtronic | 131.35 Bn | 96.86 Bn | 6.34 Bn | 2.49 Bn |
| 6 | Stryker | 119.87 Bn | 106.06 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.39 Bn | 59.83 Bn | 3.43 Bn | 1.19 Bn |
| 8 | Edwards Lifesciences | 60.93 Bn | 44.24 Bn | 1.35 Bn | 344.00 Mn |
| 9 | Medline | 52.61 Bn | 49.74 Bn | 1.93 Bn | 769.00 Mn |
| 10 | Nephros | 35.98 Mn | 17.32 Mn | 3.29 Mn | 533,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 533,000.00 |
| Jun 30, 2026 | 1.85 Mn |
| Mar 31, 2026 | 124,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | 348,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 606,000.00 |
| Dec 31, 2024 | 352,000.00 |
| Sep 30, 2024 | 239,000.00 |
| Jun 30, 2024 | -282,000.00 |
| Mar 31, 2024 | -166,000.00 |
| Dec 31, 2023 | -598,000.00 |
| Sep 30, 2023 | -156,000.00 |
| Jun 30, 2023 | -390,000.00 |
| Mar 31, 2023 | -252,000.00 |
| Dec 31, 2022 | -638,000.00 |
| Sep 30, 2022 | -1.21 Mn |
| Jun 30, 2022 | -734,000.00 |
| Mar 31, 2022 | -1.46 Mn |
| Dec 31, 2021 | -631,000.00 |
API Access
Nephros EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=NEPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "NEPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=NEPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();